United Therapeutics
在场
是其中之一......
United Therapeutics 是一家在股票代码 UTHR (US) 下上市的公司。
高管
查看带有其 32 名主要高管的组织结构图
United Therapeutics 搜索最多的简介
- Martine Rothblatt, Chairman of the Board and Chief Executive Offic...
- Judy Olian, Director
- Louis Sullivan, Director
高管在United Therapeutics变化
- Jan Malcolm已作为Director加入公司 (新闻发布的2024六月27号).
创建提醒
跟踪 United Therapeutics 的高管变动
生物技术
United Therapeutics 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
- Metsera 刚刚宣布为 500 筹款数百万美元。 (公布2024十一月20号).
- TRexBio 刚刚宣布为 84 筹款数百万美元。 (公布2024十一月14号).
生物技术 行业的其他推荐联系人
消息
United Therapeutics 的最新新闻稿
- United Therapeutics Corporation to Present at the UBS Global Healthcare Conference
- United Therapeutics Corporation Reports Third Quarter 2024 Financial Results
- United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024
- United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service
- United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever
- United Therapeutics Corporation to Present at Upcoming Investor Conferences
- United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
- United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors
- United Therapeutics Corporation Reports First Quarter 2024 Financial Results
- United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program
- View more press releases Close
通过电子邮件
